LZTFL1

LZTFL1 is a cytoplasmic and ciliary trafficking regulator that governs the dynamics of the BBSome complex during ciliogenesis (PMID:22072986, PMID:34446551). It physically associates with the BBSome and acts as a negative regulator of BBSome ciliary entry, since LZTFL1 depletion restores BBSome trafficking in cells lacking BBS3 (ARL6) or BBS5 (PMID:22072986). Mechanistically, LZTFL1 maintains BBSome dynamics through a dual mechanism: it promotes BBS3/ARL6 targeting to the basal body to direct BBSome loading onto anterograde IFT trains, and it stabilizes the IFT25/27 subcomplex to enable BBSome reassembly at the ciliary tip for retrograde transport (PMID:34446551), with the requirement for IFT27 stabilization confirmed in vivo (PMID:34023333). Through this control of ciliary trafficking, LZTFL1 negatively regulates Hedgehog signaling, restraining ciliary Smoothened, Patched1, and GLI2 such that its loss in patient cells produces massive Shh pathway activation (PMID:22072986, PMID:22510444). Loss of LZTFL1 disrupts ciliary architecture and protein sorting in photoreceptors, causing rhodopsin mislocalization and photoreceptor apoptosis (PMID:27312011), and is required for normal sperm flagellar structure and male fertility (PMID:34023333). Beyond cilia, LZTFL1 binds β-catenin in the cytoplasm to block its nuclear translocation and suppress EMT, migration, and invasion (PMID:25005785), inhibits TGF-β-activated MAPK and Hedgehog signaling in lung epithelial cells (PMID:26364604), destabilizes AKT via the ZNRF1 ubiquitin-proteasome pathway to enforce G1 arrest in kidney tumor cells (PMID:36966254), and modulates hypothalamic leptin receptor/STAT3 signaling, with knockout mice showing hyperphagia and leptin resistance (PMID:30423168). At the immunological synapse, LZTFL1 redistributes upon T cell–APC engagement and modulates TCR/NFAT signaling and cytokine output (PMID:26700766). LZTFL1 expression is controlled post-transcriptionally and by enhancers at the 3p21.31 locus, where a risk allele upregulates LZTFL1 in association with EMT activation in lung epithelium of severe COVID-19 patients (PMID:34737427, PMID:34998241).

1. 2011 High

   Established LZTFL1 as a direct physical partner and negative regulator of the BBSome, answering where it sits relative to BBSome ciliary entry and linking it to Hedgehog signal transduction.

   Evidence Reciprocal Co-IP, siRNA knockdown with double-knockdown epistasis, and ciliary localization imaging of Smoothened in mammalian cells

   PMID:22072986

   Open questions at the time

   • Did not resolve the molecular step at which LZTFL1 blocks BBSome entry
   • Smoothened readout was correlative localization rather than direct binding
2. 2012 Medium

   Confirmed in human loss-of-function cells that LZTFL1 is a negative regulator of Shh signaling, validating the ciliopathy-relevant pathway consequence of its loss.

   Evidence Western blot and RT-PCR of Smoothened, Patched1, and GLI2 in patient fibroblasts carrying a frameshift deletion

   PMID:22510444

   Open questions at the time

   • Single patient genotype
   • Did not distinguish direct ciliary trafficking effects from secondary transcriptional changes
3. 2014 Medium

   Defined a cilium-independent role: LZTFL1 sequesters β-catenin in the cytoplasm to suppress EMT, broadening its function into Wnt-associated tumor suppression.

   Evidence Reciprocal Co-IP, in situ proximity ligation, and migration/invasion/zymography assays in gastric cancer cells

   PMID:25005785

   Open questions at the time

   • Binding interface on β-catenin not mapped
   • Single cancer cell context
4. 2015 Medium

   Extended the EMT-suppressive role to lung epithelium and demonstrated in vivo tumor suppression, tying LZTFL1 to ciliated-cell differentiation and TGF-β/MAPK/Hedgehog signaling.

   Evidence Re-expression in tumor lines, pathway Western blots, and in vivo colonization assays in mice

   PMID:26364604

   Open questions at the time

   • Multiple pathways implicated without defining the primary direct target
   • Single lab
5. 2015 Medium

   Identified a role in immune cells, showing LZTFL1 redistributes to the immunological synapse and tunes TCR-mediated NFAT signaling and cytokine output.

   Evidence Live-cell imaging, knockdown/overexpression, NFAT luciferase reporter, and cytokine ELISA in CD4+ T cells

   PMID:26700766

   Open questions at the time

   • Molecular partners at the synapse not identified
   • Connection to ciliary trafficking machinery unclear
6. 2016 Medium

   Defined the in vivo ciliary phenotype of LZTFL1 loss, showing it regulates BBSome ciliary content and is required for photoreceptor outer segment integrity and protein sorting.

   Evidence Lztfl1 knockout mice with immunofluorescence, fractionation, TUNEL, and electron microscopy of photoreceptors

   PMID:27312011

   Open questions at the time

   • Mechanism linking AP1 adaptor increase to rhodopsin mislocalization not resolved
   • Single model organism readout
7. 2018 Medium

   Placed LZTFL1 in hypothalamic leptin signaling, showing its loss abolishes leptin-stimulated STAT3 phosphorylation and drives obesity through a brain-specific requirement.

   Evidence Global and tissue-specific knockout mice, leptin-stimulated STAT3 phosphorylation Western blots, cilia measurement, and Co-IP

   PMID:30423168

   Open questions at the time

   • Step at which LZTFL1 couples LepRb to STAT3 not defined
   • Actin/cytoskeleton interactors not individually validated
8. 2021 High

   Resolved the dual molecular mechanism of LZTFL1 in BBSome dynamics — basal-body recruitment via BBS3/ARL6 and tip reassembly via IFT25/27 stabilization — using a tractable ciliary genetic system.

   Evidence Chlamydomonas genetics, IFT imaging assays, Co-IP, and combinatorial mutant epistasis

   PMID:34446551

   Open questions at the time

   • Conservation of the exact dual mechanism in mammalian cilia not fully demonstrated
   • Structural basis of BBS3 and IFT25/27 binding unresolved
9. 2021 Medium

   Confirmed in vivo that LZTFL1 specifically stabilizes IFT27, linking its trafficking function to flagellar assembly and male fertility.

   Evidence Knockout mouse with selective loss of testicular IFT27, sperm motility analysis, and in vitro fertilization

   PMID:34023333

   Open questions at the time

   • Direct LZTFL1–IFT27 binding interface not mapped
   • Whether stabilization is via direct binding or pathway effect unresolved
10. 2021 Medium

    Identified how the 3p21.31 COVID-19 risk locus acts, showing the risk allele enhancer upregulates LZTFL1 in association with EMT activation in patient lung epithelium.

    Evidence Chromosome conformation capture, expression analysis, and spatial transcriptomics of patient biopsies with machine learning

    PMID:34737427

    Open questions at the time

    • Causal chain from LZTFL1 upregulation to disease severity not experimentally dissected
    • EMT association is correlative in tissue
11. 2021 Medium

    Defined a post-transcriptional control mechanism, showing the SNHG6 lncRNA recruits PTBP1 to destabilize LZTFL1 mRNA in hepatoma cells.

    Evidence Quantitative proteomics, RNA immunoprecipitation, and mRNA stability assays

    PMID:34252487

    Open questions at the time

    • Functional consequence of LZTFL1 loss in this context not fully traced
    • Single cancer model
12. 2022 Medium

    Functionally confirmed that the COVID-19 GWAS locus regulates LZTFL1 transcription, validating LZTFL1 as the causal gene at the locus.

    Evidence CRISPRi targeting near rs11385942 in intron 5 with qRT-PCR in lung epithelial cell lines

    PMID:34998241

    Open questions at the time

    • Downstream phenotypic effect of reduced LZTFL1 not measured here
    • Single cell-line context
13. 2023 Medium

    Defined a proliferation-control mechanism, showing LZTFL1 destabilizes AKT through the ZNRF1 ubiquitin-proteasome pathway to enforce G1 arrest.

    Evidence Gain/loss-of-function in kidney tumor lines, PDX rescue, AKT Western blots, and cell cycle analysis

    PMID:36966254

    Open questions at the time

    • Direct LZTFL1–ZNRF1 interaction not structurally characterized
    • Single tumor type
14. 2024 Medium

    Linked LZTFL1 to canonical Wnt/β-catenin signaling and adipogenesis, showing its loss in MSCs suppresses Wnt activation and favors fat differentiation.

    Evidence Knockout MSCs analyzed by Western blot, flow cytometry, lipid-raft fractionation, and cell-surface LRP6 assay

    PMID:39662832

    Open questions at the time

    • Mechanism connecting LZTFL1 to CAV1/LRP6 raft organization unresolved
    • Single cell system
15. 2024 Low

    Implicated LZTFL1 in Th2 differentiation via an ERK/GATA3 axis in allergic airway inflammation.

    Evidence Lentiviral shRNA knockdown in an OVA asthma mouse model with Western blot, flow cytometry, and cytokine ELISA

    PMID:38310669

    Open questions at the time

    • ERK→GATA3 protein stabilization not directly demonstrated
    • Mechanism inferred indirectly
    • Single lab

• How LZTFL1's conserved ciliary trafficking function mechanistically connects to its many non-ciliary roles (β-catenin, AKT/ZNRF1, leptin/STAT3, ERK/GATA3) remains unresolved, as does the structural basis of its interactions.
• No structural model of LZTFL1 with BBSome, BBS3, or IFT25/27
• Whether cytoplasmic signaling roles are separable from ciliary trafficking unknown
• No unifying biochemical activity defined